AIMS-2-TRIALS researchers Emily Jones and Samantha Els publish blog sharing an overview of the impact of project programs on childhood neurodevelopmental outcomes
In this blog, “Bridging the gap: Improving outcomes for children with neurodevelopmental conditions,” published by the European Federation of Pharmaceutical Industries and Associations, AIMS-2-TRIALS researchers highlight the need for better understanding, earlier support, and more personalised approaches for autistic children and their families. The blog discusses how AIMS-2-TRIALS is addressing these needs across different settings while making research more accessible and relevant to everyday life.
To read it, please visit:
https://www.efpia.eu/news-events/the-efpia-view/blog-articles/bridging-the-gap-improving-outcomes-for-children-with-neurodevelopmental-conditions-guest-blog/
